Pulmonary antibody mediated rejection (AMR) after lung transplantation is an important cause of acute and chronic allograft dysfunction. It is critical that the lung transplant clinician, pathologist and immunologist have a strong understanding of the criteria for the diagnosis and assessment of AMR and of the approaches used to manage these patients. Understanding the clinical, pathological and immunological features of AMR will help to close the practice gap in specialist knowledge. We are delighted to offer for the second time this interactive educational opportunity to update the knowledge in this complex diagnostic scenario.
The interactive symposium is aimed at experienced lung transplant specialists (Pulmonologists/Respirologists, Surgeons, Pathologists, Immunologists) that should routinely work in a multidisciplinary team for a more sensitive and accurate diagnosis and appropriate management of this complication.